TOPIC CENTER
98 Articles
Updated Oct 5, 2026
Regulatory & Compliance
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
Regulatory & ComplianceTeva and Alvotech Set to Transform Humira Market with Simlandi FDA Approval
4 min read • 2 years ago -
Regulatory & ComplianceFDA Halts Neumora’s Schizophrenia Drug Trials Over Preclinical Safety Concerns
4 min read • 2 years ago -
Regulatory & ComplianceStudy Reveals Many Fast-Tracked Cancer Drugs Fail to Show Long-Term Benefits
4 min read • 2 years ago -
Regulatory & ComplianceFDA Approves First BCMA-Targeted Relapsed or Refractory Multiple Myeloma Therapy
4 min read • 2 years ago -
-
Regulatory & ComplianceFDA Approves Zevtera for Multiple Bacterial Infections
4 min read • 2 years ago -
-
Regulatory & ComplianceFDA Approves New PAH Treatments: OPSYNVI® and Winrevair
4 min read • 2 years ago -
Regulatory & ComplianceFDA Rejects Regeneron’s Blood Cancer Therapy Odronextamab Pending More Data
4 min read • 2 years ago -
-
Regulatory & ComplianceBioNTech Faces NIH Default Notice Over COVID-19 Vaccine Royalties
4 min read • 2 years ago
Stay Ahead in Pharma Intelligence
Join industry executives receiving our market briefings.
